Evidence map›Paper›PMID 41374075›Full record

ArticleNutrients2025

Clinical Impact of the Geriatric Nutritional Risk Index on Chemotherapy-Related Adverse Events in Diffuse Large B-Cell Lymphoma: A Multicenter Study.

Kei Fujita, Hikaru Tsukasaki, Shin Lee, Tetsuji Morishita, Eiju Negoro, Kana Oiwa, Takeshi Hara, Hisashi Tsurumi, Takanori Ueda, Takahiro Yamauchi

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kei FujitaDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.
Hikaru TsukasakiDepartment of Hematology, Juko-Osu Hospital, 2-2-43 Osu, Naka-ku, Nagoya 460-0017, Japan.
Shin LeeDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.ORCID 0000-0002-1984-2369
Tetsuji MorishitaDepartment of Internal Medicine, Matsunami General Hospital, Gifu 501-6062, Japan.ORCID 0000-0002-7225-2819
Eiju NegoroDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.ORCID 0000-0003-2010-9567
Kana OiwaDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.
Takeshi HaraDepartment of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-cho, Hashima-gun, Gifu 501-6062, Japan.
Hisashi TsurumiDepartment of Hematology and Oncology, Matsunami General Hospital, Dendai 185-1 Kasamatsu-cho, Hashima-gun, Gifu 501-6062, Japan.
Takanori UedaDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.
Takahiro YamauchiDepartment of Hematology and Oncology, University of Fukui, 23-3, Matsuoka-Shitago, Eiheiji-cho, Yoshida-gun, Fukui 910-1193, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsDrug-Related Side Effects and Adverse ReactionsGeriatric AssessmentLymphoma, Large B-Cell, DiffuseNutritional StatusNutrition AssessmentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentAntineoplastic Agentsdiffuse large B-cell lymphomaGeriatric Nutritional Risk Indexnutritional assessmentreal-world evidencetoxicity prediction

Identifiers

PMID41374075
PMCPMC12694119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.